Charter portfolio company Swift Biosciences has partnered with LGC Biosearch Technologies to incorporate Swift’s targeted sequencing technology into LGC’s kits and service offerings for the worldwide ag-bio market.
As part of the collaboration, LGC will be Swift’s worldwide partner for amplicon-based targeted sequencing assays for genotyping ag-bio samples, including crop species and animals.
Based off Swift’s Accel-Amplicon products, LGC’s products and services will use Swift’s primer design, algorithms, multiplex PCR chemistry, and next-generation sequencing library preparation reagents to achieve mid-density SNP genotyping by sequencing for high-sample-throughput applications.
“Swift developed a patented, multiplex PCR library preparation technology to enable sequencing thousands of targets per assay and primer design software that accommodates various plant and animal genomes,” Drew McUsic, senior product manager at Ann Arbor, Michigan-based Swift, said in a statement. “Partnering with LGC allows Swift to focus the application of that technology into the ag-bio market.” Read more at genomeweb